Credit Suisse’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-51,931
| Closed | -$2M | – | 3192 |
|
|
2023
Q2 | $2M | Buy |
51,931
+17,680
| +52% | +$679K | ﹤0.01% | 1898 |
|
|
2023
Q1 | $793K | Buy |
34,251
+2,074
| +6% | +$48K | ﹤0.01% | 2447 |
|
|
2022
Q4 | $843K | Buy |
32,177
+2,624
| +9% | +$68.7K | ﹤0.01% | 2444 |
|
|
2022
Q3 | $581K | Buy |
29,553
+2,821
| +11% | +$55.5K | ﹤0.01% | 2683 |
|
|
2022
Q2 | $467K | Buy |
+26,732
| New | +$467K | ﹤0.01% | 2869 |
|
|
2020
Q1 | – | Sell |
-2,328
| Closed | -$14K | – | 3540 |
|
|
2019
Q4 | $14K | Sell |
2,328
-3,210
| -58% | -$19.3K | ﹤0.01% | 3455 |
|
|
2019
Q3 | $29K | Buy |
5,538
+713
| +15% | +$3.73K | ﹤0.01% | 3397 |
|
|
2019
Q2 | $37K | Buy |
4,825
+82
| +2% | +$629 | ﹤0.01% | 3371 |
|
|
2019
Q1 | $94K | Buy |
4,743
+795
| +20% | +$15.8K | ﹤0.01% | 3260 |
|
|
2018
Q4 | $52K | Sell |
3,948
-5,635
| -59% | -$74.2K | ﹤0.01% | 3260 |
|
|
2018
Q3 | $352K | Buy |
9,583
+3,379
| +54% | +$124K | ﹤0.01% | 2988 |
|
|
2018
Q2 | $217K | Buy |
6,204
+1,518
| +32% | +$53.1K | ﹤0.01% | 3279 |
|
|
2018
Q1 | $218K | Buy |
4,686
+490
| +12% | +$22.8K | ﹤0.01% | 3256 |
|
|
2017
Q4 | $157K | Sell |
4,196
-3,502
| -45% | -$131K | ﹤0.01% | 3291 |
|
|
2017
Q3 | $409K | Buy |
7,698
+4,732
| +160% | +$251K | ﹤0.01% | 3121 |
|
|
2017
Q2 | $169K | Sell |
2,966
-1,451
| -33% | -$82.7K | ﹤0.01% | 3263 |
|
|
2017
Q1 | $237K | Sell |
4,417
-1,169
| -21% | -$62.7K | ﹤0.01% | 3215 |
|
|
2016
Q4 | $318K | Sell |
5,586
-1,097
| -16% | -$62.5K | ﹤0.01% | 3277 |
|
|
2016
Q3 | $415K | Sell |
6,683
-506
| -7% | -$31.4K | ﹤0.01% | 3189 |
|
|
2016
Q2 | $406K | Sell |
7,189
-3,348
| -32% | -$189K | ﹤0.01% | 3244 |
|
|
2016
Q1 | $676K | Buy |
10,537
+5,474
| +108% | +$351K | ﹤0.01% | 2733 |
|
|
2015
Q4 | $712K | Buy |
+5,063
| New | +$712K | ﹤0.01% | 2891 |
|